No, Trump Didn’t Actually Save Natalie Harp’s Life
Those who would defend the president’s disturbingly close relationship with his young, blonde aide keep claiming that one of his policies saved her life. It’s a highly dubious claim.

Just a reminder: No, President Donald Trump did not save Natalie Harp’s life.
As the president’s close relationship with his female aide has come under scrutiny, a litany of MAGA social media accounts have jumped to her defense. Notably, numerous accounts have claimed their relationship is nothing if not honorable—after all, Harp credits Trump’s 2018 Right to Try Act with saving her life.
In an emotional address at the 2020 Republican National Convention, Harp claimed that after she was diagnosed with stage 2 bone cancer, she was a beneficiary of Trump’s policy intended to give patients access to experimental medical treatments.
“When I failed the chemotherapies that were on the market, no one wanted me in their clinical trials,” Harp said. “They didn’t give me the right to try experimental treatments, Mr. President. You did, and without you, I’d have died waiting for them to be approved.”
But experts have long cast doubt on Harp’s supposedly heartwrenching story.
Harp claimed she received “an FDA-approved immunotherapy drug for an unapproved use,” but Trump’s Right to Try law only applies to drugs that have not been approved by the FDA. Healthcare providers were already allowed to prescribe FDA-approved drugs for off-label uses long before Trump ever entered office.
In reality, Trump’s Right to Try was a massive failure—a repackaging of the expanded access that patients already had with decreased federal oversight. The president’s claims that the program has saved thousands of lives couldn’t be further from the truth. The most recent report shows the policy supported access to only six drugs in 2025.
Years after helping him sell his lame duck policy, Harp is still glued to Trump’s side. After the president tapped his “human binkie” to join him on his secret flight out of Turkey last month, people are starting to suggest there may be more to the story—and the White House’s wild reaction did little to ease concerns.



